We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





Siemens Healthineers Showcases Role of Digitalization at AACC 2018

By LabMedica International staff writers
Posted on 31 Jul 2018
Print article
Image: A screenshot of the Atellica Data Manager (Photo courtesy of Siemens Healthineers).
Image: A screenshot of the Atellica Data Manager (Photo courtesy of Siemens Healthineers).
At the 70th AACC Annual Scientific Meeting & Clinical Lab Expo, Siemens Healthineers (Erlangen, Germany) showcased an array of digital offerings that turn data into actionable information to address a variety of clinical and operational challenges facing laboratories.

Siemens Healthineers provided a preview of the soon-to-be-released Atellica Data Manager that delivers clinical details lab managers need to make informed decisions. Atellica Data Manager operationalizes data from patient samples and QC results to standardize testing, optimize QC performance, and maximize the potential of autoverification while reducing operator interventions, unwarranted variations and errors. Open and scalable, Atellica Data Manager is built on the powerful CentraLink solution currently in use by 1,500+ laboratories in more than 50 countries to help optimize clinical operations, increase testing volumes and improve turnaround times.

At AACC 2018, Siemens Healthineers displayed Atellica Inventory Manager, which provides automated, real-time control over reagents and consumables across multiple lab locations to reduce inventory costs, save time, and improve efficiencies. Pre-labeled radio frequency identification (RFID) tags simplify inventory check-in, checkout, and consumption tracking, and, when enabled, consumables can be ordered automatically through cloud-enabled software.

Also on display at the event was Atellica Process Manager, which in addition to offering laboratories centralized control and visibility, now provides advanced analytics and business intelligence capabilities, enabling labs to gain real-time insight into hidden inefficiencies in their workflow. Out-of-the box and interactive reports enable lab managers to assess key metrics such as turnaround times, testing volumes, problem samples, and automation utilization.

Additionally, the company displayed POCcelerator Data Management System which is designed to address daily point-of-care challenges such as quality control, compliance and operator certification, and offers point-of-care coordinators vendor-neutral, open connectivity to more than 170 devices, giving coordinators visibility into results, quality controls, operators, reagents, and device data. The information is presented in a clear and structured format. Proactive error logs and a traffic-light system indicate potential problems that can be acknowledged with a single click.

Siemens Healthineers demonstrated its investment in transforming healthcare through digital innovations with its Digital Ecosystem. The open and secured cloud environment combines data from lab and imaging devices, which can be leveraged by applications from Siemens Healthineers and other partner companies to provide solutions to the lab. The company also showcased its first lab partner XIFIN and demonstrated how its Revenue Cycle Management solution helps to optimize the laboratory’s financial performance, by identifying potential outreach and outpatient testing reimbursement gaps.

Complementing the company’s digital offerings, Siemens Healthineers featured its Laboratory As A Business (LAAB) Consulting Service designed to address clinical, operational and financial challenges of laboratories, and help position the lab as a decision maker and a powerful contributor to the objectives of value-based care in health systems. LAAB recommends or structures sustainable solutions that help achieve strategic business objectives by leveraging the capabilities of the lab and informatics offerings, expertise, and competencies from Siemens Healthineers.

Gold Member
Chagas Disease Test
CHAGAS Cassette
Verification Panels for Assay Development & QC
Seroconversion Panels
New
cTnI/CK-MB/Myo Test
Finecare cTnI/CK-MB/Myo Rapid Quantitative Test
New
Gold Member
Human Chorionic Gonadotropin Test
hCG Quantitative - R012

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.